- Home
- BFLY vs PCRX Comparison
BFLY vs PCRX Comparison
Compare BFLY & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFLY
- PCRX
- Stock Information
- Founded
- BFLY 2011
- PCRX 2006
- Country
- BFLY United States
- PCRX United States
- Employees
- BFLY N/A
- PCRX N/A
- Industry
- BFLY Medical Electronics
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- BFLY Health Care
- PCRX Health Care
- Exchange
- BFLY Nasdaq
- PCRX Nasdaq
- Market Cap
- BFLY 1.1B
- PCRX 1.2B
- IPO Year
- BFLY N/A
- PCRX 2011
- Fundamental
- Price
- BFLY $2.43
- PCRX $25.72
- Analyst Decision
- BFLY Buy
- PCRX Buy
- Analyst Count
- BFLY 1
- PCRX 9
- Target Price
- BFLY N/A
- PCRX $30.11
- AVG Volume (30 Days)
- BFLY 3.0M
- PCRX 941.7K
- Earning Date
- BFLY 05-02-2025
- PCRX 05-06-2025
- Dividend Yield
- BFLY N/A
- PCRX N/A
- EPS Growth
- BFLY N/A
- PCRX N/A
- EPS
- BFLY N/A
- PCRX N/A
- Revenue
- BFLY $82,056,000.00
- PCRX $700,966,000.00
- Revenue This Year
- BFLY $21.50
- PCRX $9.48
- Revenue Next Year
- BFLY $25.34
- PCRX $11.31
- P/E Ratio
- BFLY N/A
- PCRX N/A
- Revenue Growth
- BFLY 24.52
- PCRX 3.85
- 52 Week Low
- BFLY $0.67
- PCRX $11.16
- 52 Week High
- BFLY $4.98
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- BFLY 46.83
- PCRX 55.39
- Support Level
- BFLY $2.20
- PCRX $25.08
- Resistance Level
- BFLY $2.57
- PCRX $26.65
- Average True Range (ATR)
- BFLY 0.19
- PCRX 1.57
- MACD
- BFLY 0.06
- PCRX 0.11
- Stochastic Oscillator
- BFLY 75.29
- PCRX 67.18
About BFLY Butterfly Network Inc.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.